Decoy Therapeutics Inc. (DCOY) Total liabilities 2016–2022
Decoy Therapeutics Inc. (DCOY) total liabilities at each fiscal year-end, per SEC filings.
$4.3MFY2022 · since FY2016: $3.9M → $4.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $4.3M | +102.1% |
| FY2021 | $2.1M | -23.9% |
| FY2020 | $2.8M | -16.3% |
| FY2019 | $3.3M | -58.0% |
| FY2018 | $7.9M | +33.9% |
| FY2017 | $5.9M | +51.0% |
| FY2016 | $3.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Net marginDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating marginDCOY Operating cash flowDCOY Free cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Shareholders’ equityDCOY overview →